Clinical Trial Detail

NCT ID NCT03414983
Title An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread (CheckMate 9X8)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

Therapies

Bevacizumab + FOLFOX

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Nivolumab

Age Groups: adult senior

No variant requirements are available.